NCT00409318View on ClinicalTrials.gov

Study of TNF-Antagonism in Metabolic Syndrome

NACompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Metabolic Syndrome

Interventions

DRUG

Etanercept

50 mg SC q week

DRUG

Placebo

SC q week

Trial Locations (1)

02114

MGH, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

Massachusetts General Hospital

OTHER